scispace - formally typeset
M

Michael H Neale

Researcher at University College London

Publications -  26
Citations -  1105

Michael H Neale is an academic researcher from University College London. The author has contributed to research in topics: Chemosensitivity assay & Melanoma. The author has an hindex of 16, co-authored 26 publications receiving 1051 citations. Previous affiliations of Michael H Neale include University of Leicester & Queen Alexandra Hospital.

Papers
More filters
Journal ArticleDOI

The E3 ubiquitin ligase Itch controls the protein stability of p63

TL;DR: It is shown that the Hect (homologous to the E6-associated protein C terminus)-containing Nedd4-like ubiquitin protein ligase Itch binds, ubiquitylates, and promotes the degradation of p63, suggesting that Itch has a fundamental role in the mechanism that controls endogenous p63 protein levels and therefore contributes to regulation of p 63 in physiological conditions.
Journal ArticleDOI

Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.

TL;DR: Though limited in number, the highest VEGF levels correlated with previous radiation therapy, and with the presence neovascularisation of the iris or optic nerve head, these data suggest that anti-VEGF therapy might prove useful in the management of some patients with NVI secondary to uveal melanoma.
Journal ArticleDOI

c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma

TL;DR: The finding of improved rather than reduced survival in inc- myc positive tumours is at variance with skin melanoma, and there was no evidence to suggest that c-myc was modulated by upregulation ofBcl-2 or p53inactivation/mutation.
Journal ArticleDOI

PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.

TL;DR: It is shown that p73α, -β, and -γ bind to the protein inhibitor of activated STAT-1 (PIAS-1) and that this binding stabilizes p73, and that PIas-1-mediated sumoylation decreases p73 transcriptional activity on several target promoters, such as Bax.